Clinical case of a patient with fatal development of gas gangrene while using totally implantable venous access devices

Area of Science:

• Infectious Diseases
• Oncology
• Critical Care Medicine

Background:

• Gas gangrene (clostridial myonecrosis) is a rare but life-threatening infection.
• Clostridium perfringens is the primary causative agent.
• The disease carries significant morbidity and mortality, particularly in immunocompromised individuals.

Purpose of the Study:

• To report a clinical case of fatal gas gangrene.
• To highlight a rare complication in an immunocompromised patient with esophageal carcinoma and a Port-a-Cath device.
• To underscore the risks associated with chemotherapy in such patients.

Main Methods:

• Clinical case presentation.
• Review of patient's medical history, including esophageal carcinoma and Port-a-Cath placement.
• Analysis of the patient's development of gas gangrene following chemotherapy.

Main Results:

• A 37-year-old male with esophageal carcinoma and a totally implantable venous access device developed fatal gas gangrene.
• The infection occurred following a course of chemotherapy.
• This case illustrates a severe, albeit rare, complication in an immunocompromised patient.

Conclusions:

• Gas gangrene can occur in immunocompromised patients with underlying malignancies and venous access devices.
• Chemotherapy may be a predisposing factor or exacerbate the risk of such infections.
• Prompt recognition and management are crucial, though outcomes can be fatal.